Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$9,149,013
+$245,532 QoQ
Shares Held
36,024
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
4.21%
of 13F equity value
Holder Rank
#1,170
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First PREMIER Bank holds $19,058,988 across 11 Drug Manufacturers - General names. JNJ ranks #1 (48.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
36,024 | $9,149,013 | |
| 2 | AMGN |
Amgen Inc
|
8,903 | $3,223,954 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,539 | $2,767,761 | |
| 4 | ABBV |
AbbVie Inc.
|
6,697 | $1,685,232 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,692 | $719,126 | |
| 6 | LLY |
ELI LILLY & Co
|
538 | $645,292 | |
| 7 | PFE |
Pfizer Inc
|
15,632 | $376,417 | |
| 8 | GSK |
GSK plc
|
4,433 | $232,377 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,149,013 | 36,024 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $8,903,481 | 36,424 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $7,702,470 | 37,219 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,033,906 | 37,935 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $6,017,433 | 39,394 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $6,548,025 | 39,484 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,779,592 | 39,964 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $6,492,769 | 40,064 | Shares | Other | 2024-10-08 | |
| 2024-06-30 | $6,322,003 | 43,254 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $6,940,425 | 43,874 | Shares | Other | 2024-04-12 | |
| 2023-12-31 | $7,155,334 | 45,651 | Shares | Other | 2024-01-17 | |
| 2023-09-30 | $7,066,842 | 45,373 | Shares | Other | 2023-10-16 | |
| 2023-06-30 | $7,663,078 | 46,297 | Shares | Other | 2023-07-13 | |
| 2023-03-31 | $7,392,880 | 47,696 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $8,393,346 | 47,514 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $7,765,152 | 47,534 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $8,420,362 | 47,436 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $8,392,902 | 47,356 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $8,022,155 | 46,894 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $7,712,109 | 47,753 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $7,937,828 | 48,184 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $7,988,723 | 48,608 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $7,633,872 | 48,506 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $7,148,174 | 48,013 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $6,744,190 | 47,957 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $6,185,006 | 47,167 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||